Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
reproductive toxicity, other
Remarks:
organ toxicity
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Data is form peer-reviewed journal

Data source

Reference
Reference Type:
publication
Title:
Short-term toxicity study in rats dosed with menthone
Author:
C.Madsen..G.Würtzen..J.Carstensen
Year:
1986
Bibliographic source:
Toxicology Letters Volume 32, Issues 1–2, July–August 1986, Pages 147-152

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
other: OECD 407
Principles of method if other than guideline:
Subacute Toxicity study of test chemical in Rats.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
trans-menthone
EC Number:
201-941-1
EC Name:
trans-menthone
Cas Number:
89-80-5
Molecular formula:
C10H18O
IUPAC Name:
(2R,5S)-5-methyl-2-(propan-2-yl)cyclohexan-1-one
Test material form:
liquid
Details on test material:
- IUPAC Name: (2R,5S)-5-methyl-2-(propan-2-yl)cyclohexan-1-one
- Common Name: Menthone/ trans-menthone
- InChI: 1S/C10H18O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-9H,4-6H2,1-3H3
- Smiles:C1([C@@H](CC[C@@H](C1)C)C (C)C)=O
- Molecular formula:C10H18O
- Molecular weight :154.2512 g/mole
- Substance type: Organic
- Physical state: Clear liquid (colourless to yellowish)
- Purity: 98% (by GC)

Test animals

Species:
rat
Strain:
other: SPF
Sex:
male/female
Details on test animals or test system and environmental conditions:
- Source: Mollegaards Breeding Centre Ltd., Ejby (DK-4623 L. Skensved).
- Age at study initiation: 4 weeks old
- Weight at study initiation:
- Fasting period before study: not specified
- Housing: The animals were kept in stainless steel wire cages (2 per cage)
- Diet (e.g. ad libitum): The rats were fed a pelleted diet (Chow 101, Institute of Toxicology, and National Food Agency). ad libitum
- Water (e.g. ad libitum): acidified water (citric acid, pH 3.5) was given ad lib.
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23’C ± 1°C,
- Humidity (%): 60 % ± 5%
- Air changes (per hr): air change 6-8 times/h,
- Photoperiod (hrs): electric light from 21.00 to 09.00 hours

Administration / exposure

Route of administration:
oral: gavage
Type of inhalation exposure (if applicable):
not specified
Vehicle:
soya oil
Details on exposure:
- Justification for use and choice of vehicle (if other than water): Soya oil
- Concentration in vehicle: 0,200,400 and 800 mg/kgbw/ day
Details on mating procedure:
- Any other deviations from standard protocol: Histopathology of reproductive organ were examined.
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
28 days
Frequency of treatment:
Daily
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day
Dose / conc.:
200 mg/kg bw/day
Dose / conc.:
400 mg/kg bw/day
Dose / conc.:
800 mg/kg bw/day
No. of animals per sex per dose:
Total: 80
0 (vehicle) mg/kg/day: 10 male, 10 female
200 mg/kg/day: 10 male, 10 female
400 mg/kg/day: 10 male, 10 female
800 mg/kg/day: 10 male, 10 female
Control animals:
yes, concurrent vehicle
Details on study design:
Not specified
Positive control:
Not specified

Examinations

Parental animals: Observations and examinations:
Survival, Clinical sign, Body weight and weight gain and clinical chemistry were examined.
Oestrous cyclicity (parental animals):
Not specified
Sperm parameters (parental animals):
Not specified
Litter observations:
Not specified
Postmortem examinations (parental animals):
Organ weight and histopathology was examined.
Postmortem examinations (offspring):
Not specified
Statistics:
Body weights, food and water consumption were compared by means of Student’s t-test. Analysis of variance was performed on haematoiogical parameters, clinical chemical parameters and absolute and relative organ weights. The mean values were compared by the method of Tukey.
Reproductive indices:
Not specified
Offspring viability indices:
Not specified

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
When treated wtih 800 mg/kg bw, after 19 days of dosing female rats showed signs of toxic effects. They had pale mucous membranes and showed signs of pain prevent deaths in this group, the dose was reduced to 400 mg/kg.
Dermal irritation (if dermal study):
not specified
Mortality:
mortality observed, treatment-related
Description (incidence):
When treated wtih 800 mg/kg bw, 4 animals died during the study due to accidental intratracheal dosing.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
Decreased in body weight gain was observed in treated male and female rats at 200, 400 and 800 mg/kg bw as compared to control.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
When treated wtih 800 mg/kg bw, Decreased in food consumption was observed in treated male rat, and in female rats from 3rd week as compared to control.
When treated with 200 and 400 mg/kg bw, Decreased in food consumption was observed in female rat within the first 2 weeks as compared to control.
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
effects observed, treatment-related
Description (incidence and severity):
When treated with 800 mg/kg bw, dose-dependent decrease of creatinine concentration and a dose dependent increase of both alkaline phosphatase activity and bilirubin content were observed in treated male and female rats as compared to control.
Urinalysis findings:
not specified
Behaviour (functional findings):
not specified
Immunological findings:
not specified
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Histopathological findings: non-neoplastic:
no effects observed
Description (incidence and severity):
Cyst-like spaces appeared scattered in the white matter of the cerebellum at 800 mg/kg bw. The findings resembled the changes found in rats dosed with peppermint oil. No histopathological changes were observed in reproductive organ of testis and ovary of treated rats as compared to control.
Histopathological findings: neoplastic:
not specified
Other effects:
not specified

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
not specified
Reproductive function: sperm measures:
not specified
Reproductive performance:
not specified

Effect levels (P0)

open allclose all
Dose descriptor:
NOAEL
Effect level:
800 mg/kg bw/day
Based on:
test mat.
Sex:
male
Basis for effect level:
histopathology: non-neoplastic
Remarks on result:
other: No effect on histopathology of reproductive organs
Dose descriptor:
NOAEL
Effect level:
671 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
histopathology: non-neoplastic
Remarks on result:
other: No effect on histopathology of reproductive organs

Target system / organ toxicity (P0)

Critical effects observed:
not specified
System:
other: not specified
Organ:
not specified

Results: F1 generation

General toxicity (F1)

Clinical signs:
not specified
Dermal irritation (if dermal study):
not specified
Mortality / viability:
not specified
Body weight and weight changes:
not specified
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Sexual maturation:
not specified
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
not specified
Histopathological findings:
not specified
Other effects:
not specified

Developmental neurotoxicity (F1)

Behaviour (functional findings):
not specified

Developmental immunotoxicity (F1)

Developmental immunotoxicity:
not specified

Effect levels (F1)

Dose descriptor:
other: not specified
Generation:
other: not specified
Based on:
not specified
Sex:
not specified
Basis for effect level:
other: not specified
Remarks on result:
other: not specified

Target system / organ toxicity (F1)

Critical effects observed:
not specified
System:
other: not specified
Organ:
not specified

Overall reproductive toxicity

Reproductive effects observed:
not specified
Treatment related:
not specified

Applicant's summary and conclusion

Conclusions:
NOAEL was considered to be 800 mg/kg bw for male and 671 mg/kg bw for female when SPF male and female rats were treated with test chemical orally by gavage for 28 days.
Executive summary:

In a repertaed dsoe toxicity study,SPF male andfemale rats were treated with test chemical in the concentration of 0, 200, 400 and 800 mg/kg bw/ day orally by gavage for 28 days.At 800 mg/kg bw,after 19 days of dosing female rats showed signs of toxic effects. They had pale mucous membranes and showed signs of pain prevent deaths in this group, the dose was reduced to 400 mg/kg.4 animals died during the study due to accidental intratracheal dosing.Decreased in body weight gain was observed in treated male and female rats at 200, 400 and 800 mg/kg bw as compared to control. Decreased in food consumption was observed in treated male rat at 800 mg/kg bw, and in female rats from 3rd week at400 mg/kg bwas compared to control. Decreased in food consumption was observed in female rat within the first 2 weeks at 200 and 400mg/kg bwas compared to control. Dose-dependent decrease in creatinine concentration and a dose dependent increase of both alkaline phosphatase activity and bilirubin content were observed in treated male and female rats at 800 mg/kg bw as compared to control. Similarly,statistically significant dose-related increase in relative weight of the spleen, liver and brain of the male rat at 800 mg/kg bw and kidneys, spleen, liver and brain of female rats at 400 mg/kg bw were observed as compare to control. In addition, Cyst-like spaces appeared scattered in the white matter of the cerebellum at 800 mg/kg bw. The findings resembled the changes found in rats dosed with peppermint oil. No histopathological changes were observed in reproductive organ of testis and ovary of treated rats as compared to control. Therefore, NOAEL was considered to be 800 mg/kg bw for male and 671 mg/kg bw for female when SPF male and female rats were treated with test chemical orally by gavage for 28 days.